Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

Mongolia

National Center for Communicable Diseases, Ulaanbaatar

Pakistan

Institute of Chest Diseases, Kotri

Peru

Hospital Nacional Sergio E. Bernales, Lima

Policlínico SES, Lima

Uganda

Mulago National Referral Hospital, Kampala